维普中文期刊产品整合服务
20篇 您的检索式:作者名="Rüschoff"
    题名 作者 年代 出处 被引量
1Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis显示文摘Moser M Rüschoff J Buettner R 0,,01:1
2HER2 in situ hybridization in breast cancer:clinical implications of polysomy 17 and genetic heterogeneity显示文摘Hanna W M R ü schoff J Bilous M 2014Mod Pathol2014,27,1:1
3Targeted therapy in metastatic breast cancer: the HER2/neu oncogene显示文摘Harbeck N Pegram MD Rüschoff J 2010Breast Care (Basel)2010,5,1:1
4HER2 testing in gastric cancer:a practical approach显示文摘Rüschoff J Hanna W Bilous M 2012Mod Pathol2012,25,5:1
5IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer显示文摘Gerrit Peters Silvia Gongoll Cord Langner Michael Mengel Pompiliu Piso Jürgen Klempnauer Josef Rüschoff Hans Kreipe Reinhard Wasielewski 2003Virchows Archiv2003,,2:1
6IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer显示文摘Gerrit Peters Silvia Gongoll Cord Langner Michael Mengel Pompiliu Piso Jürgen Klempnauer Josef Rüschoff Hans Kreipe Reinhard Wasielewski 2003Virchows Archiv2003,,2:1
7Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:20
8Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet . 2010 (9742)2010,,9742:6
9Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:2
10Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 20102010 (9742)2010,,9742:2
11Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
12HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing显示文摘Josef Rüschoff Manfred Dietel Gustavo Baretton Susanne Arbogast Axel Walch Geneviéve Monges Marie-Pierre Chenard Frédérique Penault-Llorca Iris Nagelmeier Werner Schlake H. H?fler H. H. Kreipe 2010Virchows Archiv2010,,3:1
13Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
14HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing显示文摘Josef Rüschoff Manfred Dietel Gustavo Baretton Susanne Arbogast Axel Walch Geneviéve Monges Marie-Pierre Chenard Frédérique Penault-Llorca Iris Nagelmeier Werner Schlake H. H?fler H. H. Kreipe 2010Virchows Archiv2010,,3:1
15Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
16Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
17HNPCC-associated small bowel cancer: Clinical and molecular characteristics显示文摘Karsten Schulmann Frank E. Brasch Erdmute Kunstmann Christoph Engel Constanze Pagenstecher Holger Vogelsang Stefan Krüger Tilman Vogel Hanns-Peter Knaebel Josef Rüschoff Stephan A. Hahn Magnus V. Knebel-Doeberitz Gabriela Moeslein Stephen J. Meltzer Hans 2005Gastroenterology2005,,:1
18Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
19HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing显示文摘Josef Rüschoff Manfred Dietel Gustavo Baretton Susanne Arbogast Axel Walch Geneviéve Monges Marie-Pierre Chenard Frédérique Penault-Llorca Iris Nagelmeier Werner Schlake H. H?fler H. H. Kreipe 2010Virchows Archiv2010,,3:1
20Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial显示文摘Yung-Jue Bang Eric Van Cutsem Andrea Feyereislova Hyun C Chung Lin Shen Akira Sawaki Florian Lordick Atsushi Ohtsu Yasushi Omuro Taroh Satoh Giuseppe Aprile Evgeny Kulikov Julie Hill Michaela Lehle Josef Rüschoff Yoon-Koo Kang 2010The Lancet2010,,9742:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费